CTSO · CIK 0001175151 · FY2025 live · 2025-12-31
Cytosorbents Corp
View as
Model
Classic Z
FY2025
−10.61
Zone
Distress
Prior
—
Market DD
—
1y PD
—
−10.61
Z″ −23.50
Score −10.61 · distress below 1.80, grey to 2.99, safe at 3.00 and above.
Classic Z factor contributions
X1 Working capital / assets
Short-term liquidity versus the size of the balance sheet.
0.251.2 × = 0.30X2 Retained earnings / assets
Cushion from years of profits. Share buybacks can push this negative at otherwise healthy firms.
−7.071.4 × = −9.89X3 EBIT / assets
Operating return on assets. Highest weight in the original model.
−0.333.3 × = −1.10X4 Book equity / liabilities
Book equity versus the liability stack. Mega-caps often look greyer here than they would if X4 used market cap.
0.150.6 × = 0.09X5 Sales / assets
Asset turnover — how much revenue the asset base supports.
0.001 × = 0.00
Five-year path
Need two annual 10-Ks to draw a path. The desk will pull this issuer’s filings rather than invent a series.
Overview
rule-v1
Cytosorbents Corp is on classic Z at −10.61 (distress) for FY2025, from an SEC 10-K. Retained earnings / assets is the line that sets the print. This is the first live year on the desk. No market tape loaded. Classic Z was fit on manufacturers; buybacks can send retained earnings negative at otherwise healthy issuers, and X4 is book equity, not market cap.
Book screen Distress; market PD —. Tape not priced — not a single default call.
Market DD · naive Merton
No market tape yet.
Pull a year of closes (Yahoo, Nasdaq if Yahoo is limited) and size equity from Nasdaq cap or EDGAR shares. Distance-to-default and 1-year PD stay blank until then.
Sector peers
Closest Classic Z scores · 15th percentile in Healthcare.
- LONADistressLeonaBio, Inc.−10.63
- SHPHDistressShuttle Pharmaceuticals Holdings, Inc.−10.63
- NEPHDistressNEPHROS INC−10.51
- ATAIDistressAtaiBeckley Inc.−10.84
- CNTBDistressConnect Biopharma Holdings Ltd−10.84
- PAVMDistressPAVmed Inc.−10.33
- ALLRDistressAllarity Therapeutics, Inc.−10.94
- NCELDistressNewcelX Ltd.−10.19
KPI widgets
Current assets
$21M
Total assets
$44M
Current liabilities
$10M
Total liabilities
$38M
Working capital
$11M
Retained earnings
−$312M
EBIT
−$15M
Total sales
$0
Book equity
$6M
Accession 0001104659-26-036451. Live rank is the latest 10-K on EDGAR (FY2025, period 2025-12-31). Classic Z is the live score. View as does not rewrite the live rank. X4 is book equity. Pulled 12 Sept 2026.